USA · PI Dr. Reyes · activated
Patients
51
Active
0
Serious AEs
0
Open QA
1
Aged queries
0
Luna users
0
Studies & contracts
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II · study completed · contract executed · 529500 USD
Patients (51)
701-1015 ›
completed
701-1023 ›
completed
701-1028 ›
completed
701-1033 ›
completed
701-1034 ›
completed
701-1047 ›
completed
701-1057 ›
screened
701-1097 ›
completed
701-1111 ›
completed
701-1115 ›
completed
701-1118 ›
completed
701-1130 ›
completed
701-1133 ›
completed
701-1145 ›
screened
701-1146 ›
completed
701-1148 ›
completed
701-1153 ›
completed
701-1162 ›
screened
701-1176 ›
screened
701-1180 ›
completed
701-1181 ›
completed
701-1188 ›
completed
701-1192 ›
completed
701-1203 ›
completed
701-1211 ›
completed
701-1234 ›
completed
701-1239 ›
completed
701-1240 ›
screened
701-1275 ›
withdrawn
701-1287 ›
completed
701-1294 ›
completed
701-1302 ›
completed
701-1307 ›
screened
701-1317 ›
completed
701-1324 ›
completed
701-1341 ›
completed
701-1345 ›
completed
701-1356 ›
screened
701-1360 ›
withdrawn
701-1363 ›
completed
701-1369 ›
screened
701-1383 ›
completed
701-1386 ›
screened
701-1387 ›
completed
701-1392 ›
completed
701-1411 ›
screened
701-1415 ›
completed
701-1429 ›
withdrawn
701-1440 ›
completed
701-1442 ›
completed
701-1444 ›
completed
Safety — 238 AEs, 0 serious
No serious adverse events.
QA findings (1 open)
open
major
PROTOCOL VIOLATION: PROTOCOL VIOLATION (subject 701-1387, 2014-03-25)
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.